Conference Coverage

Time to HIV rebound in infants off ART linked to birth health

 

Key clinical point: Early initiation of antiretroviral therapy in infants is associated with better outcomes.

Major finding: Longer time to viral rebound was associated with higher baseline CD4, higher birth weight, and viral suppression within 40 weeks of starting ART.

Study details: Analysis of outcomes in 183 infants with HIV infection in the CHER trial.

Disclosures: The study was funded by the U.S. National Institutes of Health. Dr. Chan reported having nothing to disclose.

Source: Violari A et al. CROI 2018, Abstract 137.


 

FROM CROI 2018


The study was the U.S. National Institutes of Health. Dr. Chan reported having nothing to disclose.

SOURCE: Violari A et al. CROI 2018, Abstract 137

Next Article:

   Comments ()